Call for International Speakers & Abstract Submission
We are pleased to announce that two special symposium sessions at JSNET2026 will be open for international abstract submission and registration.
We warmly invite physicians, researchers, and trainees from around the world to participate and contribute to these unique international platforms.
Submission Deadline
Tuesday, June 30, 2026, 5:00 PM JST
- To submit abstracts, please send it to the congress secretariat of JSNET2026 (jsnet2026@convex.co.jp) via email by the submission deadline.
- All abstracts must be submitted (and if accepted, will be presented) in English.
- Proofread abstracts carefully to avoid errors before the submission deadline.
Submission Requirements
- Contact Information: Provide the full name, institution, and country.
- Co-authors: Please note that up to 11 co-authors can be registered.
- Category Selection: Choose one category and write it at the top of your abstract.
#1 Do not be afraid of language barriers!
Next-generation international exchange opened by AI translation
This session aims to foster a new form of international exchange by introducing cutting-edge real-time AI translation technology, enabling truly interactive discussions beyond language barriers. We warmly invite submissions from both Japanese participants who may feel hesitant about presenting or engaging in discussions in English, as well as international speakers who are not familiar with Japanese.
The session will cover all aspects of neuroendovascular therapy.
All discussions, including Q&A, will be conducted through an AI-based translation application, allowing seamless communication between English and Japanese.
We welcome participants who are motivated not by language proficiency, but by a genuine desire to share their clinical insights with the global community. Join us in exploring a new era of international collaboration.
#2 International Symposium
While neurovascular treatment has seen remarkable global progress, significant differences remain in healthcare environments, indications, and regulatory frameworks across countries.
This session invites the next generation of physicians and researchers to present:
- The current status of neuroendovascular therapy in their country
- Clinical challenges and unique circumstances
- Their own research activities
We also encourage speakers to share their personal commitment and vision for the future of the field.
This session is an ideal platform for those making their debut in English-language presentations. Let’s create a vibrant international forum where young passion meets innovation.
Important Notice
- Only the above two sessions are open for international abstract submission and registration.
- All other sessions will follow standard domestic submission policies.
- Abstract Title:
- An abstract must have a short, specific title (containing no abbreviations or inflammatory language) that indicates the nature of the investigation.
- Abstract Text:
- Abstracts may have the following identifiable sections: Introduction, Hypothesis, Methods, Results and Conclusions.
- Abstracts should be limited to approximately 300 words, excluding the title and authors. Spaces do not count as characters. Figures or tables should not be included in the abstract.
- Author Name(s):
- The submitting author is designated as the primary and presenting author.
- Please review the author block carefully. Additions or deletions of author names are not permitted after the submission deadline.
We look forward to your participation
Join us at JSNET2026 and be part of shaping the future of
neuroendovascular therapy through global collaboration and innovation.
Inquiry
Convex Secretariat for JSNET2026
c/o Convex Inc.
E-mail: jsnet2026@convex.co.jp
